Don’t forget you can visit MyAlerts to manage your alerts at any time.
By Kristen Rasmussen | June 12, 2017
Last week, the U.S. Food and Drug Administration asked Endo Pharmaceuticals Inc. to remove Opana ER, its extended-release version of oxymorphone hydrochloride, from the market after the agency found a likelihood of abuse by crushing up and injecting the pills.
1 minute read
By Amanda Bronstad | June 12, 2017
On Monday, a jury came out with a defense verdict in the second trial over the blood thinner. That's about a month after Johnson & Johnson and Bayer won the first bellwether trial over Xarelto.
1 minute read
By Max Mitchell | June 9, 2017
The upcoming antitrust trial over Cephalon's alleged reverse-payment settlements with generic drug companies needs to be bifurcated at the liability phase, a federal judge has ruled.
1 minute read
By Jennifer Williams-Alvarez | June 9, 2017
For close to a decade, the Federal Trade Commission has been trying to get its hands on documents from drugmaker Boehringer Ingelheim Pharmaceuticals Inc., resulting in a yearslong dispute over what documents and communications are protected when an in-house counsel is involved.
1 minute read
By Kristen Rasmussen | June 9, 2017
In what the Cherokee Nation described as "an attack on the very sovereignty of our nation," several pharmaceutical distributors and retail pharmacies have asked a federal judge to prevent a lawsuit against them over the opioid addiction epidemic from proceeding in tribal court.
1 minute read
By Michael Booth | June 8, 2017
A federal judge has ordered a Pennsylvania doctor and her husband to pay Novartis Pharmaceuticals Corp. $1.87 million in fee sanctions and counterclaim damages in a discrimination lawsuit that was deemed to have been lodged in bad faith.
1 minute read
By Kristen Rasmussen | June 7, 2017
A Long Island physician is using a novel defense against federal prosecutors accusing him of overprescribing narcotic painkillers: The drug manufacturers are responsible.
1 minute read
By Rhys Dipshan | June 7, 2017
When the legal department at Baxter needed to quickly review a large batch of contracts, it turned to AI. But the technology was far from ready out of the box.
1 minute read
Delaware Business Court Insider
By Tom McParland | June 6, 2017
Amgen Inc. has asked a Delaware federal judge to temporarily block Hospira Inc. from bringing a biosimilar version of its anemia-fighting drug Epogen to market, saying the competitor failed to provide the company proper notice under a 2010 law.
1 minute read
By Christine Simmons | June 5, 2017
Katten Muchin Rosenman's legal advice will likely be the target of heavy scrutiny in the upcoming trial against former pharmaceutical executive Martin Shkreli—unless the government has its way.
1 minute read
Presented by BigVoodoo
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
The Daily Report is honoring those attorneys and judges who have made a remarkable difference in the legal profession.
Consulting Magazine identifies consultants that have the biggest impact on their clients, firms and the profession.
Company Description CourtLaw Injury Lawyers is an established Personal Injury Law Firm with its primary office located in Perth Amboy, New J...
Black Owl Recruiting is looking for a number of qualified applicants to fill positions for a highly reputable client. Recent experience work...
McManimon, Scotland & Baumann, LLC is seeking talented and motivated Associate Attorneys with 3-7 years of experience working closely wi...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS